GS-9620 (vesatolimod)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-9620 (vesatolimod), covering 2013-11-14 to 2013-11-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B [Phase 1]